GGrantIndex
← Search

CCSG Supplement: To Strengthen the Research, Training, and Outreach Capacity

$199,691P30FY2023CANIH

Fred Hutchinson Cancer Center, Seattle WA

Investigators

Linked publications, trials & patents

Trial NCT06995898Trial NCT06682039Trial NCT06484595Trial NCT06193070Trial NCT05947500Trial NCT05930496Trial NCT05183828Trial NCT04902144Trial NCT04751383Trial NCT04682301Trial NCT04667481Trial NCT04660331Trial NCT04539366Trial NCT04505553Trial NCT04502524Trial NCT04500548Trial NCT04496219Trial NCT04489719Trial NCT04472338Trial NCT04466475Trial NCT04447313Trial NCT04444232Trial NCT04442581Trial NCT04431479Trial NCT04410900Trial NCT04387227Trial NCT04384692Trial NCT04383743Trial NCT04375631Trial NCT04372927Trial NCT04370301Trial NCT04359784Trial NCT04336943Trial NCT04329065Trial NCT04282187Trial NCT04260776Trial NCT04257578Trial NCT04254133Trial NCT04231877Trial NCT04220229Trial NCT04211766Trial NCT04208724Trial NCT04205409Trial NCT04200482Trial NCT04198922Trial NCT04196010Trial NCT04195945Trial NCT04195633Trial NCT04194918Trial NCT04188912Trial NCT04175431Trial NCT04156828Trial NCT04155840Trial NCT04151940Trial NCT04120246Trial NCT04111497Trial NCT04083183Trial NCT04083170Trial NCT04081779Trial NCT04081298Trial NCT04062955Trial NCT04060849Trial NCT03999515Trial NCT03991884Trial NCT03986502Trial NCT03980769Trial NCT03970096Trial NCT03907527Trial NCT03891784Trial NCT03864419Trial NCT03807063Trial NCT03806192Trial NCT03781778Trial NCT03779867Trial NCT03779854Trial NCT03778021Trial NCT03776864Trial NCT03749460Trial NCT03747484Trial NCT03737955Trial NCT03723863Trial NCT03718338Trial NCT03672981Trial NCT03670966Trial NCT03670069Trial NCT03660930Trial NCT03649841Trial NCT03641287Trial NCT03606486Trial NCT03602898Trial NCT03600038Trial NCT03585231Trial NCT03574012Trial NCT03570476Trial NCT03531918Trial NCT03525106Trial NCT03523195Trial NCT03522584Trial NCT03518242Trial NCT03516812

Abstract

Abstract The Fred Hutchinson/University of Washington/Seattle Children’s Cancer Consortium is deeply committed to increasing the diversity of the cancer research workforce. Central to our efforts is enhancing our existing partnerships with Minority-Serving Institutions (MSIs), as well as developing new partnerships. Summer undergraduate training programs currently exist between our cancer center and Morehouse College (a HBCU), Spelman College (a HBCU), and New Mexico State University (a Hispanic-Serving Institution). Additionally, we have experience identifying and supporting the career development of scholars and early-stage investigators throughout the west coast through our 10+ year history leading our region’s NCI-funded Center to Reduce Cancer Disparities (CRCHD) Geographic Management of Cancer Health Disparities Program (GMaP). In particular, our current 2-year GMaP cycle directly engaged with 83 potential CURE scholars and supported them by providing annual career development workshops, expert grant reviews, research stimulus awards, and conference travel awards. Thus, we are ideally positioned to execute this supplement and achieve each of the following specific aims: Aim 1: Identify URM trainees and ESIs through our cancer center’s Minority Serving Institution (MSI) partners and engage them in the NCI/NIH-supported scholar pathway programs with an emphasis on those interested in cancer health disparities research. Aim 2: Provide robust and comprehensive support for the career development of URM trainees and ESIs by providing career development workshops tailored to their specific needs, 1:1 support for grant writing through leveraging our team of Training Navigators (TNs), and awarding travel scholarships. Aim 3: Track and monitor the progress and productivity of newly identified URM scholars and develop tailored strategies to support each of their longer-term career development plans. A critical element of our program is our cadre of 8 Training Navigators who are faculty at our cancer center and all of whom themselves are underrepresented racial and ethnic minorities based on the NIH definition. Our aims will be completed through partnering with a total of 8 MSIs including five that we have existing collaborative programs/relationships with (Morehouse College, New Mexico State University, Spelman College, the University of California, Irvine, and the University of Guam) and three that are new partnerships (Clark Atlanta University, Diné College, and Stillman College). Of note, these institutions include a mix of four HBCUs, two Hispanic-Serving Institutions, one Tribal College, and two Pacific Islander-Serving Institutions.

View original record on NIH RePORTER →